Potential therapeutic value of melatonin in diabetic nephropathy: improvement beyond anti-oxidative stress

References

• Abdel-Wahab, M.H., and Abd-Allah, A.R., 2000. Possible protective effect of melatonin and/or desferrioxamine against streptozotocin-induced hyperglycaemia in mice. Pharmacological research, 41, 533–537.
   PubMed Web of Science ®Google Scholar
• Agarwal, A., and Nick, H.S., 2000. Renal response to tissue injury: lessons from heme oxygenase-1 GeneAblation and expression. Journal of the American society of nephrology, 11 (5), 965–973.
   PubMed Web of Science ®Google Scholar
• Agil, A., et al., 2015. Melatonin reduces hepatic mitochondrial dysfunction in diabetic obese rats. Journal of pineal research, 59 (1), 70–79.
   PubMed Web of Science ®Google Scholar
• Akhmedov, A.T., Rybin, V., and Marin-Garcia, J., 2015. Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart. Heart failure reviews, 20, 227–249.
   PubMed Web of Science ®Google Scholar
• Alderton, W.K., Cooper, C.E., and Knowles, R.G., 2001. Nitric oxide synthases: structure, function and inhibition. Biochemical journal, 357, 593–615.
   PubMed Web of Science ®Google Scholar
• Andersson, A.K., and Sandler, S., 2001. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells. Journal of pineal research, 30, 157–165.
   PubMed Web of Science ®Google Scholar
• Anon, 2013. Low melatonin secretion is a risk factor for type 2 diabetes. BMJ, 346, f2202.
   PubMedGoogle Scholar
• Bach, A.G., et al., 2005. Melatonin stimulates inositol-1,4,5-trisphosphate and Ca2+ release from INS1 insulinoma cells. Journal of pineal research, 39, 316–323.
   PubMed Web of Science ®Google Scholar
• Bazwinsky-Wutschke, I., et al., 2014. Influence of melatonin receptor signalling on parameters involved in blood glucose regulation. Journal of pineal research, 56, 82–96.
   PubMed Web of Science ®Google Scholar
• Bonnefont-Rousselot, D., and Collin, F., 2010. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology, 278, 55–67.
   PubMed Web of Science ®Google Scholar
• Bouatia-Naji, N., et al., 2009. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nature genetics, 41, 89–94.
   PubMed Web of Science ®Google Scholar
• Brosius, F.C., 3rd., et al., 1992. Insulin-responsive glucose transporter expression in renal microvessels and glomeruli. Kidney international, 42, 1086–1092.
   PubMed Web of Science ®Google Scholar
• Brown, D.R., et al., 1997. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Experimental neurology, 146, 104–112.
   PubMed Web of Science ®Google Scholar
• Brydon, L., et al., 2001. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology, 142, 4264–4271.
   PubMed Web of Science ®Google Scholar
• Cao, W., et al., 2015. A salt-induced reno-cerebral reflex activates renin-angiotensin systems and promotes CKD progression. Journal of the American society of nephrology, 26 (7), 1619–1633.
   PubMed Web of Science ®Google Scholar
• Carretero, M., et al., 2009. Long-term melatonin administration protects brain mitochondria from aging. Journal of pineal research, 47, 192–200.
   PubMed Web of Science ®Google Scholar
• Catherwood, M.A., et al., 2002. Glucose-induced oxidative stress in mesangial cells. Kidney international, 61, 599–608.
   PubMed Web of Science ®Google Scholar
• Ceriello, A., et al., 2000. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes, 49 (12), 2170–2177.
   PubMed Web of Science ®Google Scholar
• Chambers, J.C., et al., 2009. Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes, 58 (11), 2703–2708.
   PubMed Web of Science ®Google Scholar
• Chang, A.S., et al., 2016. Transforming growth factor-beta1 and diabetic nephropathy. American journal of physiology: renal physiology, 310, F689–F696.
   PubMed Web of Science ®Google Scholar
• Chuang, J.I., et al., 2016. Melatonin prevents the dynamin-related protein 1-dependent mitochondrial fission and oxidative insult in the cortical neurons after 1-methyl-4-phenylpyridinium treatment. Journal of pineal research, 61, 230–240.
   PubMed Web of Science ®Google Scholar
• Ciftci, M., Bilici, D., and Kufrevioglu, O.I., 2001. Effects of melatonin on enzyme activities of glucose-6-phosphate dehydrogenase from human erythrocytes in vitro and from rat erythrocytes in vivo. Pharmacological research, 44, 7–11.
   PubMed Web of Science ®Google Scholar
• Coughlan, M.T., et al., 2007. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology, 148, 886–895.
   PubMed Web of Science ®Google Scholar
• D’Agord Schaan, B., et al., 2001. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes. Hormone and metabolic research, 33 (11), 664–669.,
   PubMed Web of Science ®Google Scholar
• De Luxan-Delgado, B., et al., 2016. Melatonin reduces endoplasmic reticulum stress and autophagy in liver of leptin-deficient mice. Journal of pineal research, 61, 108–123.
   PubMed Web of Science ®Google Scholar
• Derubertis, F.R., Craven, P.A., and Melhem, M.F., 2007. Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metabolism, 56, 1256–1264.
   PubMed Web of Science ®Google Scholar
• Dominguez, J.H., et al., 1992. Glucose transporters of rat proximal tubule: differential expression and subcellular distribution. American journal of physiology, 262, F807–12.
   PubMedGoogle Scholar
• Dong, C., et al., 2015. Heme oxygenase-1 enhances autophagy in podocytes as a protective mechanism against high glucose-induced apoptosis. Experimental cell research, 337, 146–159.
   PubMed Web of Science ®Google Scholar
• Doosti-Irani, A., et al., 2018. The effects of melatonin supplementation on glycemic control: a systematic review and meta-analysis of randomized controlled trials. Hormone and metabolic research, 50, 783–790.
   PubMed Web of Science ®Google Scholar
• Ebaid, H., et al., 2020. Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress. Nutrition & metabolism, 17, 6.
   PubMed Web of Science ®Google Scholar
• Elbe, H., et al., 2015. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Human & experimental toxicology, 34 (1), 100–113.
   PubMed Web of Science ®Google Scholar
• Elrod, J.W., et al., 2010. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. Journal of clinical investigation, 120, 3680–3687.
   PubMed Web of Science ®Google Scholar
• Ersahin, M., et al., 2009. Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. Journal of pineal research, 47, 97–106.
   PubMed Web of Science ®Google Scholar
• Escames, G., et al., 2006. Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: effects of melatonin treatment. Experimental gerontology, 41, 1165–1173.
   PubMed Web of Science ®Google Scholar
• Farrokhian, A., et al., 2019. Effect of bedtime melatonin administration in patients with type 2 diabetes: a triple-blind, placebo-controlled, randomized trial. Iranian journal of pharmaceutical research, 18, 258–268.
   PubMed Web of Science ®Google Scholar
• Fernández Vázquez, G., Reiter, R.J., and Agil, A., 2018. Melatonin increases brown adipose tissue mass and function in Zucker diabetic fatty rats: implications for obesity control. Journal of pineal research, 64 (4), e12472.
   PubMed Web of Science ®Google Scholar
• Forbes, J.M., Coughlan, M.T., and Cooper, M.E., 2008. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes, 57, 1446–1454.
   PubMed Web of Science ®Google Scholar
• Garfinkel, D., et al., 2011. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes, metabolic syndrome and obesity: targets and therapy, 4, 307–313.
   PubMedGoogle Scholar
• Gill, P.S., and Wilcox, C.S., 2006. NADPH oxidases in the kidney. Antioxid redox signal, 8, 1597–1607.
   PubMed Web of Science ®Google Scholar
• Girouard, H., et al., 2003. Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rats. Journal of hypertension, 21, 179–188.
   PubMed Web of Science ®Google Scholar
• Gnudi, L., et al., 2003. GLUT-1 overexpression: link between hemodynamic and metabolic factors in glomerular injury? Hypertension, 42 (1), 19–24.
   PubMed Web of Science ®Google Scholar
• Gruden, G., et al., 2000. Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes, 49 (4), 655–661.
   PubMed Web of Science ®Google Scholar
• Han, Y.S., et al., 2020. melatonin protects human renal proximal tubule epithelial cells against high glucose-mediated fibrosis via the cellular prion protein-TGF-beta-smad signaling axis. International journal of medical sciences, 17, 1235–1245.
   PubMed Web of Science ®Google Scholar
• Hardeland, R., et al., 2012. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. Journal of pineal research, 52, 139–166.
   PubMed Web of Science ®Google Scholar
• Heilig, C., et al., 1995a. Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney. Laboratory investigation, 73, 674–684.
   PubMed Web of Science ®Google Scholar
• Heilig, C.W., et al., 1995b. Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. Journal of clinical investigation, 96, 1802–1814.
   PubMed Web of Science ®Google Scholar
• Heilig, C.W., et al., 2001. Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression. American journal of physiology-renal physiology, 280, F657–F666.
   PubMed Web of Science ®Google Scholar
• Heilig, C.W., et al., 1997. D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy. Diabetes, 46 (6), 1030–1039.
   PubMed Web of Science ®Google Scholar
• Henry, D.N., et al., 1999. Glucose transporters control gene expression of aldose reductase, PKCalpha, and GLUT1 in mesangial cells in vitro. American Journal of Physiology, 277, F97–F104.
   PubMedGoogle Scholar
• Hevia, D., et al., 2015. Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer. Journal of pineal research, 58, 234–250.
   PubMed Web of Science ®Google Scholar
• Ho, F.M., et al., 2000. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation, 101, 2618–2624.
   PubMed Web of Science ®Google Scholar
• Hsiao, C.W., et al., 2013. Long-term Abeta exposure augments mCa2+-independent mROS-mediated depletion of cardiolipin for the shift of a lethal transient mitochondrial permeability transition to its permanent mode in NARP cybrids: a protective targeting of melatonin. Journal of pineal research, 54, 107–125.
   PubMed Web of Science ®Google Scholar
• Hsieh, T.J., et al., 2006. Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling. Kidney international, 69, 1005–1015.
   PubMed Web of Science ®Google Scholar
• Ighodaro, O.M., 2018. Molecular pathways associated with oxidative stress in diabetes mellitus. Biomedicine & pharmacotherapy, 108, 656–662.
   PubMed Web of Science ®Google Scholar
• Inoki, K., et al., 1999. TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney international, 55, 1704–1712.
   PubMed Web of Science ®Google Scholar
• Ishigaki, S., et al., 2016. Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease. Clinical and Experimental Nephrology, 20, 878–884.
   PubMed Web of Science ®Google Scholar
• Jandeleit-Dahm, K., and Cooper, M.E., 2006. Hypertension and diabetes: role of the renin-angiotensin system. Endocrinology and metabolism clinics of North America, 35, 469–490, vii.
   PubMed Web of Science ®Google Scholar
• Ji, Z.Z., and Xu, Y.C., 2016. Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model. Molecular medicine reports, 14 (1), 920–926.
   PubMed Web of Science ®Google Scholar
• Jimenez-Aranda, A., et al., 2013. Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. Journal of pineal research, 55 (4), 416–423.
   PubMed Web of Science ®Google Scholar
• Juncos, R., and Garvin, J.L., 2005. Superoxide enhances Na-K-2Cl cotransporter activity in the thick ascending limb. American journal of physiology-renal physiology, 288 (5), F982–7.
   PubMed Web of Science ®Google Scholar
• Kadhim, H.M., et al., 2006. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. Journal of pineal research, 41, 189–193.
   PubMed Web of Science ®Google Scholar
• Kamiyama, M., et al., 2013. Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy. International journal of molecular sciences, 14, 23045–23062.
   PubMed Web of Science ®Google Scholar
• Kan, M.Y., et al., 2010. Two susceptible diabetogenic variants near/in MTNR1B are associated with fasting plasma glucose in a Han Chinese cohort. Diabetic medicine, 27, 598–602.
   PubMed Web of Science ®Google Scholar
• Kang, J.W., Hong, J.M., and Lee, S.M., 2016. Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis. Journal of pineal research, 60, 383–393.
   PubMed Web of Science ®Google Scholar
• Kanter, M., et al., 2006. Depression of glucose levels and partial restoration of pancreatic beta-cell damage by melatonin in streptozotocin-induced diabetic rats. Archives of toxicology, 80, 362–369.
   PubMed Web of Science ®Google Scholar
• Kanwar, Y.S., et al., 2011. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annual review of pathology: mechanisms of disease, 6, 395–423.
   PubMed Web of Science ®Google Scholar
• Kashihara, N., et al., 2010. Oxidative stress in diabetic nephropathy. Current medicinal chemistry, 17, 4256–4269.
   PubMed Web of Science ®Google Scholar
• Kato, H., et al., 2015. Melatonin promotes adipogenesis and mitochondrial biogenesis in 3T3-L1 preadipocytes. Journal of pineal research, 59, 267–275.
   PubMed Web of Science ®Google Scholar
• Kim, W., et al., 2019. Melatonin ameliorates cuprizone-induced reduction of hippocampal neurogenesis, brain-derived neurotrophic factor, and phosphorylation of cyclic AMP response element-binding protein in the mouse dentate gyrus. Brain and behavior, 9, e01388.
   PubMed Web of Science ®Google Scholar
• Kobori, H., et al., 2007. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacological reviews, 59, 251–287.
   PubMed Web of Science ®Google Scholar
• Kobori, H., and Nishiyama, A., 2004. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochemical and biophysical research communications, 315, 746–750.
   PubMed Web of Science ®Google Scholar
• Kobori, H., and Urushihara, M., 2013. Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease. Pflugers Arch, 465, 3–12.
   PubMed Web of Science ®Google Scholar
• Koya, D., et al., 2003. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. Journal of the American society of nephrology, 14, S250–S3.
   PubMed Web of Science ®Google Scholar
• Krakowski, G., and Cieciura, L., 1985. Ultrastructural studies on the pinealocyte mitochondria during the daytime and at night. Journal of pineal research, 2, 315–324.
   PubMed Web of Science ®Google Scholar
• Lan, R., et al., 2016. Mitochondrial Pathology and Glycolytic Shift during Proximal Tubule Atrophy after Ischemic AKI. Journal of the American society of nephrology, 27, 3356–3367.
   PubMed Web of Science ®Google Scholar
• Lee, J.H., Han, Y.S., and Lee, S.H., 2017. Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression. Journal of pineal research, 62. doi:10.1111/jpi.12385
   Web of Science ®Google Scholar
• Leibowitz, A., et al., 2016. Melatonin prevents kidney injury in a high salt diet-induced hypertension model by decreasing oxidative stress. Journal of pineal research, 60 (1), 48–54.
   PubMed Web of Science ®Google Scholar
• Lewko, B., et al., 2005. Characterization of glucose uptake by cultured rat podocytes. Kidney and blood pressure research, 28, 1–7.
   PubMed Web of Science ®Google Scholar
• Li, J., Qu, X., and Bertram, J.F., 2009. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. American journal of pathology, 175 (4), 1380–1388.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2018. Melatonin exerts an inhibitory effect on insulin gene transcription via MTNR1B and the downstream Raf1/ERK signaling pathway. International journal of molecular medicine, 41, 955–961.
   PubMed Web of Science ®Google Scholar
• Lin, G.J., et al., 2009. Melatonin prolongs islet graft survival in diabetic NOD mice. Journal of pineal research, 47, 284–292.
   PubMed Web of Science ®Google Scholar
• Liu, C., et al., 2010. MTNR1B rs10830963 is associated with fasting plasma glucose, HbA1C and impaired beta-cell function in Chinese Hans from Shanghai. BMC medical genetics, 11, 59.
   PubMed Web of Science ®Google Scholar
• Liu, Z., et al., 2018. Melatonin alleviates adipose inflammation through elevating alpha-ketoglutarate and diverting adipose-derived exosomes to macrophages in mice. Journal of pineal research, 64. doi:10.1111/jpi.12455
   Web of Science ®Google Scholar
• Liu, Z.H., et al., 2001. Glucose transporter in human glomerular mesangial cells modulated by transforming growth factor-beta and rhein. Acta pharmacologica sinica, 22, 169–175.
   PubMed Web of Science ®Google Scholar
• Maassen, J.A., et al., 2004. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes, 53 , S103–S9.
   PubMed Web of Science ®Google Scholar
• Marcus, R.G., et al., 1994. Altered renal expression of the insulin-responsive glucose transporter GLUT4 in experimental diabetes mellitus. American journal of physiology, 267, F816–24.
   PubMedGoogle Scholar
• Martin, M., et al., 2000. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB journal, 14, 1677–1679.
   PubMed Web of Science ®Google Scholar
• Martin, M., et al., 2002. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. International journal of biochemistry & cell biology, 34, 348–357.
   PubMed Web of Science ®Google Scholar
• Mason, R.M., and Wahab, N.A., 2003. Extracellular matrix metabolism in diabetic nephropathy. Journal of the American society of nephrology, 14, 1358–1373.
   PubMed Web of Science ®Google Scholar
• Mayo, J.C., et al., 2018. Melatonin uptake by cells: an answer to its relationship with glucose? Molecules, 23 (8), 1999.
   PubMed Web of Science ®Google Scholar
• Mcmullan, C.J., et al., 2013. Melatonin secretion and the incidence of type 2 diabetes. JAMA, 309, 1388–1396.
   PubMed Web of Science ®Google Scholar
• Mi, L., and Kuang, H., 2020. Melatonin regulates cisplatin resistance and glucose metabolism through hippo signaling in hepatocellular carcinoma cells. Cancer management and research, 12, 1863–1874.
   PubMed Web of Science ®Google Scholar
• Mott, J.L., et al., 2004. Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A. Biochemical and biophysical research communications, 319, 1210–1215.
   PubMed Web of Science ®Google Scholar
• Nangaku, M., 2004. Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Internal medicine, 43, 9–17.
   PubMed Web of Science ®Google Scholar
• Nath, K.A., et al., 2001. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. American journal of pathology, 158, 893–903.
   PubMed Web of Science ®Google Scholar
• Navar, L.G., 2014. Intrarenal renin-angiotensin system in regulation of glomerular function. Current opinion in nephrology and hypertension, 23, 38–45.
   PubMed Web of Science ®Google Scholar
• Navarro-Alarcon, M., et al., 2014. Melatonin and metabolic regulation: a review. Food & function, 5, 2806–2832.
   PubMed Web of Science ®Google Scholar
• Neufeld-Cohen, A., et al., 2016. Circadian control of oscillations in mitochondrial rate-limiting enzymes and nutrient utilization by PERIOD proteins. Proceedings of the national academy of sciences of the United States of America, 113, E1673–82.
   PubMed Web of Science ®Google Scholar
• Ostadmohammadi, V., et al., 2020. The effects of melatonin supplementation on parameters of mental health, glycemic control, markers of cardiometabolic risk, and oxidative stress in diabetic hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Journal of renal nutrition, 30 (3), 242–250.
   PubMed Web of Science ®Google Scholar
• Ostergaard, J.A., Cooper, M.E., and Jandeleit-Dahm, KaM., 2020. Targeting oxidative stress and anti-oxidant defence in diabetic kidney disease. Journal of nephrology, 33, 917–929.
   PubMed Web of Science ®Google Scholar
• Owino, S., et al., 2018. Nocturnal activation of melatonin receptor type 1 signaling modulates diurnal insulin sensitivity via regulation of PI3K activity. Journal of pineal research, 64. doi:10.1111/jpi.12462
   PubMed Web of Science ®Google Scholar
• Pacher, P., et al., 2005. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Current medicinal chemistry, 12, 267–275.
   PubMed Web of Science ®Google Scholar
• Paradies, G., et al., 2015. Protective role of melatonin in mitochondrial dysfunction and related disorders. Archives of toxicology, 89, 923–939.
   PubMed Web of Science ®Google Scholar
• Paradies, G., et al., 2010. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. Journal of pineal research, 48 (4), 297–310.
   PubMed Web of Science ®Google Scholar
• Parameyong, A., et al., 2013. Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma SH-SY5Y cells. Journal of pineal research, 55, 313–323.
   PubMed Web of Science ®Google Scholar
• Paterson, A.W., Curtis, J.C., and Macleod, N.K., 2008. Complex I specific increase in superoxide formation and respiration rate by PrP-null mouse brain mitochondria. Journal of neurochemistry, 105, 177–191.
   PubMed Web of Science ®Google Scholar
• Pauly, P.C., and Harris, D.A., 1998. Copper stimulates endocytosis of the prion protein. Journal of biological chemistry, 273, 33107–33110.
   PubMed Web of Science ®Google Scholar
• Pei, H., et al., 2016. Melatonin prevents adverse myocardial infarction remodeling via Notch1/Mfn2 pathway. Free radical biology and medicine, 97, 408–417.
   PubMed Web of Science ®Google Scholar
• Peschke, E., Bahr, I., and Muhlbauer, E., 2015. Experimental and clinical aspects of melatonin and clock genes in diabetes. Journal of pineal research, 59, 1–23.
   PubMed Web of Science ®Google Scholar
• Peschke, E., et al., 2006. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. Journal of pineal research, 40 (2), 135–143.
   PubMed Web of Science ®Google Scholar
• Peschke, E., et al., 2011. The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus). Diabetologia, 54, 1831–1840.
   PubMed Web of Science ®Google Scholar
• Peschke, E., and Muhlbauer, E., 2010. New evidence for a role of melatonin in glucose regulation. Best practice & research clinical endocrinology & metabolism, 24, 829–841.
   PubMed Web of Science ®Google Scholar
• Pisoschi, A.M., and Pop, A., 2015. The role of antioxidants in the chemistry of oxidative stress: a review. European journal of medicinal chemistry, 97, 55–74.
   PubMed Web of Science ®Google Scholar
• Prokopenko, I., et al., 2009. Variants in MTNR1B influence fasting glucose levels. Nature genetics, 41, 77–81.
   PubMed Web of Science ®Google Scholar
• Rajah, T.T., Olson, A.L., and Grammas, P., 2001. Differential glucose uptake in retina- and brain-derived endothelial cells. Microvascular research, 62 (3), 236–242.
   PubMed Web of Science ®Google Scholar
• Rasmussen, D.D., et al., 1999. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology, 140, 1009–1012.
   PubMed Web of Science ®Google Scholar
• Rocha, C.S., et al., 2014. Melatonin alters the glycolytic profile of Sertoli cells: implications for male fertility. Molecular human reproduction, 20, 1067–1076.
   PubMed Web of Science ®Google Scholar
• Rubio-Sastre, P., et al., 2014. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep, 37 (10), 1715–1719.
   PubMed Web of Science ®Google Scholar
• Sagoo, M.K., and Gnudi, L., 2018. Diabetic nephropathy: is there a role for oxidative stress? Free radical biology and medicine, 116, 50–63.
   PubMed Web of Science ®Google Scholar
• Shah, S.V., et al., 2007. Oxidants in chronic kidney disease. Journal of the American society of nephrology, 18, 16–28.
   PubMed Web of Science ®Google Scholar
• She, M., et al., 2014a. Melatonin rescues 3T3-L1 adipocytes from FFA-induced insulin resistance by inhibiting phosphorylation of IRS-1 on Ser307. Biochimie, 103, 126–130.
   PubMed Web of Science ®Google Scholar
• She, M., et al., 2014b. Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats. European journal of pharmacology, 727, 60–65.
   PubMed Web of Science ®Google Scholar
• Shi, S., et al., 2019. Melatonin attenuates acute kidney ischemia/reperfusion injury in diabetic rats by activation of the SIRT1/Nrf2/HO-1 signaling pathway. Bioscience reports, 39, BSR20181614.
   PubMed Web of Science ®Google Scholar
• Simko, F., et al., 2018. Effect of melatonin on the renin-angiotensin-aldosterone system in l-NAME-induced hypertension. Molecules, 23 (2), 265.
   PubMed Web of Science ®Google Scholar
• Singh, R., et al., 2003. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. Journal of the American society of nephrology, 14, 873–880.
   PubMed Web of Science ®Google Scholar
• Smirnova, E., et al., 2001. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Molecular biology of the cell, 12, 2245–2256.
   PubMed Web of Science ®Google Scholar
• Sonmez, M.F., et al., 2012. Melatonin and vitamin C ameliorate alcohol-induced oxidative stress and eNOS expression in rat kidney. Renal failure, 34, 480–486.
   PubMed Web of Science ®Google Scholar
• Soranzo, N., et al., 2010. Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes, 59, 3229–3239.
   PubMed Web of Science ®Google Scholar
• Stebelova, K., Herichova, I., and Zeman, M., 2007. Diabetes induces changes in melatonin concentrations in peripheral tissues of rat. Neuroendocrinology letters, 28, 159–165.
   PubMed Web of Science ®Google Scholar
• Stumpf, I., Muhlbauer, E., and Peschke, E., 2008. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells. Journal of pineal research, 45, 318–327.
   PubMed Web of Science ®Google Scholar
• Suen, D.F., Norris, K.L., and Youle, R.J., 2008. Mitochondrial dynamics and apoptosis. Genes and development, 22, 1577–1590.
   PubMed Web of Science ®Google Scholar
• Suwanjang, W., et al., 2016. Melatonin prevents cytosolic calcium overload, mitochondrial damage and cell death due to toxically high doses of dexamethasone-induced oxidative stress in human neuroblastoma SH-SY5Y cells. Neurochemistry international, 97, 34–41.
   PubMed Web of Science ®Google Scholar
• Sward, P., and Rippe, B., 2012. Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability. Acta Physiologica , 204, 294–307.
   PubMed Web of Science ®Google Scholar
• Tan, D.X., et al., 2011. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obesity reviews, 12, 167–188.
   PubMed Web of Science ®Google Scholar
• Tan, D.X., et al., 2016. Melatonin: a mitochondrial targeting molecule involving mitochondrial protection and dynamics. International journal of molecular sciences, 17, 2124.
   PubMed Web of Science ®Google Scholar
• Thomas, M.C., et al., 2005. Interactions between renin angiotensin system and advanced glycation in the kidney. Journal of the American society of nephrology, 16 (10), 2976–2984.
   PubMed Web of Science ®Google Scholar
• Thorens, B., Lodish, H.F., and Brown, D., 1990. Differential localization of two glucose transporter isoforms in rat kidney. American journal of physiology, 259, C286–94.
   PubMedGoogle Scholar
• Vallon, V., 2020. Glucose transporters in the kidney in health and disease. Pflugers Arch, 472, 1345–1370.
   PubMed Web of Science ®Google Scholar
• Vitale, S.G., et al., 2016. How to achieve high-quality oocytes? the key role of myo-inositol and melatonin. International journal of endocrinology, 2016, 4987436.
   PubMed Web of Science ®Google Scholar
• Wang, W., et al., 2018. Effects of melatonin on diabetic nephropathy rats via Wnt/beta-catenin signaling pathway and TGF-beta-Smad signaling pathway. International journal of clinical and experimental pathology, 11, 2488–2496.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2010. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis. American journal of physiology: renal physiology, 299, F99–F111.
   PubMed Web of Science ®Google Scholar
• Wang, Z., et al., 2009. Melatonin, a potent regulator of hemeoxygenase-1, reduces cardiopulmonary bypass-induced renal damage in rats. Journal of pineal research, 46, 248–254.
   PubMed Web of Science ®Google Scholar
• Weigert, C., et al., 2003. Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. Diabetes, 52, 527–535.
   PubMed Web of Science ®Google Scholar
• Wilson, D.F., 2017. Oxidative phosphorylation: regulation and role in cellular and tissue metabolism. Journal of physiology, 595, 7023–7038.
   PubMed Web of Science ®Google Scholar
• Winiarska, K., et al., 2016. Melatonin nephroprotective action in Zucker diabetic fatty rats involves its inhibitory effect on NADPH oxidase. Journal of pineal research, 60, 109–117.
   PubMed Web of Science ®Google Scholar
• Wolf, G., 2004. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. European journal of clinical investigation, 34, 785–796.
   PubMed Web of Science ®Google Scholar
• Wood, I.S., and Trayhurn, P., 2003. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. British journal of nutrition, 89, 3–9.
   PubMed Web of Science ®Google Scholar
• Wu, C.C., et al., 2012. Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy. Journal of pineal research, 52, 460–469.
   PubMed Web of Science ®Google Scholar
• Wu, H., et al., 2017. Melatonin-mediated upregulation of GLUT1 blocks exit from pluripotency by increasing the uptake of oxidized vitamin C in mouse embryonic stem cells. FASEB Journal, 31, 1731–1743.
   PubMed Web of Science ®Google Scholar
• Wu, N., et al., 2013. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell, 49, 1167–1175.
   PubMed Web of Science ®Google Scholar
• Yavuz, O., et al., 2003. Protective effect of melatonin on beta-cell damage in streptozotocin-induced diabetes in rats. Acta histochemica, 105 (3), 261–266.
   PubMed Web of Science ®Google Scholar
• Zanquetta, M.M., et al., 2003. Calorie restriction reduces pinealectomy-induced insulin resistance by improving GLUT4 gene expression and its translocation to the plasma membrane. Journal of pineal research, 35, 141–148.
   PubMed Web of Science ®Google Scholar
• Zarjou, A., and Agarwal, A., 2012. Heme oxygenase-1 as a target for TGF-beta in kidney disease. Seminars in nephrology, 32, 277–286.
   PubMed Web of Science ®Google Scholar
• Zavadil, J., and Bottinger, E.P., 2005. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 24, 5764–5774.
   PubMed Web of Science ®Google Scholar
• Zeisberg, E.M., et al., 2008. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. Journal of the American society of nephrology, 19, 2282–2287.
   PubMed Web of Science ®Google Scholar
• Zhang, H., et al., 2011. Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db/db mice. Journal of pineal research, 51, 338–344.
   PubMed Web of Science ®Google Scholar
• Zhang, S., et al., 2018. Enhanced renal afferent arteriolar reactive oxygen species and contractility to endothelin-1 are associated with canonical wnt signaling in diabetic mice. Kidney and blood pressure research, 43 (3), 860–871.
   PubMed Web of Science ®Google Scholar